Cargando...

Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights

Triple negative breast cancer (TNBC) heterogeneity and limited therapeutic options confer its phenotypic aggressiveness. The discovery of anti-TNBC natural products with valid molecular target(s) and defined pharmacodynamic profile would facilitate their therapeutic nutraceutical use by TNBC patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nutrients
Autores principales: Qusa, Mohammed H., Abdelwahed, Khaldoun S., Siddique, Abu Bakar, El Sayed, Khalid A.
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8157589/
https://ncbi.nlm.nih.gov/pubmed/34069906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu13051706
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!